Mediclinic Middle East
1 clinical trials · Sponsor
◉ Watch Mediclinic Middle East
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab And Tamoxifen Among Women With Advanced Hormone Receptor Positive Breast Cancer And Esr1 Mutation (NCT03879174) | Mediclinic Middle East | 2019-08-01 |
Track Mediclinic Middle East automatically
Every clearance here is in the API, with alerts when new ones post.